The surgical management of atrial fibrillation (AF) is an evolving field with a history of testing various lesion sets and ablation technologies. Previous animal models of AF require a chronic intervention to make AF reliably inducible. Our objective was to create an acute, reliable, and reproducible porcine model of sustained AF. To accomplish this, 21 adult domestic pigs underwent median sternotomy. Methods to induce AF were then performed sequentially: manual stimulation, rapid pacing (200 beats per minute), and then rapid pacing of 8 beats with a cycle length of 300 milliseconds, followed by an extra stimulus at decreasing cycle lengths. If AF was not induced, burst pacing was performed at a cycle length of 90 milliseconds for 30 seconds. If AF was still not induced, intravenous neostigmine was administered, and the process was repeated. Atrial fibrillation was considered sustained after 1 minute. Attempts at AF induction were successful in 18 (86%) of 21. Atrial fibrillation was induced during manual stimulation in four (19%), during rapid pacing in five (24%), during burst pacing in five (24%), and after the administration of neostigmine in four (19%). Mean (SD) duration of AF was 3.6 (2.6) minutes. Of the 18, 14 (78%) reverted to sinus rhythm spontaneously and 4 (22%) required an antiarrhythmic. This technique of inducing AF can easily be used to evaluate new technologies and lesion sets without the need for creating a chronic animal model.
A trial fibrillation (AF) is the most common sustained arrhythmia, occurring in approximately 1% of the general population and approximately 10% of patients older than 80 years. 1, 2 The criterion standard for the surgical treatment of AF, the Cox-Maze procedure, has a cure rate of more than 90% in our experience. 3 Because the operation is technically challenging, groups have attempted to use various energy sources to create ablation lines to replace the surgical lesions of the Cox-Maze procedure. These include cryoablation, radiofrequency energy (both unipolar and bipolar), ultrasound, laser, and microwave. 4Y11 Alternative lesion sets have been proposed as well. Furthermore, catheter-based interventions are becoming mainstream. 12 These new and promising technologies have the potential to change the approach to the treatment of AF.
Ideally, before clinical implementation of a novel ablation technique for the treatment of AF, the efficacy of the therapy should first be evaluated in an animal model. Several animal models exist, but they require chronic atrial pacing, induction of heart failure, or surgical atrial enlargement. 13, 14 Such models, although adequate, represent a large cost and time burden. A simple and reliable method of sustained AF is needed to test new lesion sets and ablation technologies. We describe here an acute porcine model fulfilling these criteria, which is reliably reproducible and does not require long-term alteration of atrial tissues.
METHODS
Twenty-one adult domestic pigs weighing 45 to 114 kg were used in this study. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH publication revised 1996). This study was performed according to our institutional policy and was approved by our animal studies committee.
Preoperatively, each animal was premedicated with intramuscularly administered telazol (4.4 mg/kg), ketamine (2.2 mg/kg), and xylozene (2.2 mg/kg); intubated; and anesthetized with 2% to 4% isoflurane. Initial intravenous access was obtained by ear vein. The animals were monitored continuously during the procedure with an electrocardiogram, pulse oximeter placed on the tail, end-tidal CO 2 , and a temperature probe. A femoral cutdown was performed, arterial access was obtained for blood pressure monitoring, and a femoral central venous catheter was placed for medication administration and central venous pressure monitoring. An arterial blood sample was obtained approximately every 30 minutes, an arterial blood gas analysis was performed, and the ventilator rate and tidal volume were adjusted accordingly to maintain a physiologic pH. Electrolyte values were checked with each blood sample and supplemented to maintain a potassium level greater than 3.0 mmol/L and an ionized calcium level greater than 1.0 mmol/L.
A median sternotomy was created, and the pericardial sac was opened. The pericardial fluid was removed by suction to expose the atria to air, and the pericardial edges were elevated with silk sutures, creating a pericardial sling. Atrial fibrillation induction was attempted by three sequential maneuvers. First, the heart was manually stimulated by retracting the heart to expose the atria. Retraction to view the posterior lateral right atrium and then the posterior lateral left atrium was performed with the hand, wearing standard surgical gloves. This would simulate AF that is induced due to mechanical stimulation as in postoperative AF.
For the second intervention, if AF did not occur with the removal of pericardial fluid and exposure to air and manual stimulation, a pacing electrode (20 mAmp, 300 milliseconds or 200 beats per minute) was placed on the superior right atrial free wall and paced for up to 30 seconds to induce AF. An S1S2 protocol was used, initially, 8 S1s at 300-millisecond interval, with an S2 starting at approximately 180 milliseconds and decreasing by 5 milliseconds until AF or the effective refractory period was reached. Then, this value minus 10 milliseconds was used to burst pace for 30 seconds. This was attempted three times or until AF was induced.
If the animal still did not fibrillate after burst pacing, 2.5 mg of intravenous neostigmine was administered, and the previous steps were repeated. Neostigmine was given to inhibit acetylcholine esterase, which increased vagal tone without significantly reducing systemic pressure. The increased vagal tone reduces atrial refractory periods increasing the inducibility of AF. The pacing and neostigmine maneuvers simulate alterations in autonomic activation, vagal innervation, and catecholamine release.
Sustained fibrillation was defined as AF for greater than 1 minute, confirmed by the continuous rhythm tracing. After AF was sustained, animals either spontaneously returned to normal sinus rhythm or were chemically cardioverted after 10 minutes with administration of an intravenous antiarrhythmic drug, bretylium (4 mg/kg) or amiodarone (10 mg/kg). At the end of the procedure, all animals were euthanized with a lethal dose of potassium injected into the ascending aorta or left ventricle.
RESULTS
All 21 animals survived to the end of the procedure. Atrial fibrillation was sustained in all but three animals, representing an 86% (18/21) success rate. Four animals (19%) spontaneously developed AF with manual stimulation alone. Five animals (24%) required rapid pacing on the right atrial free wall to induce AF. Five additional animals (24%) developed sustained AF with burst pacing. Four animals (19%) did not respond to the previously mentioned steps and but developed sustained AF after neostigmine (Fig. 1) . Atrial fibrillation was sustained for 3.6 (2.6) minutes (range, 1Y10 minutes). Fourteen animals (78%) reverted to sinus rhythm spontaneously, whereas four animals (22%) required the administration of an antiarrhythmic. No animals required electrical cardioversion for hemodynamic instability.
In the animals that did not sustain AF, one fibrillated transiently for 20 seconds. This animal did not receive neostigmine. The remaining two animals maintained sinus rhythm despite the administration of neostigmine. There was no association found when evaluating the impact of weight on inability to induce AF. The animals that did not develop AF were 45, 81, and 91 kg in size.
DISCUSSION
The success of this study represents an acute model of AF. Nearly all the animals in this study sustained AF without pharmacologic intervention. Of the 21 animals in the study, AF was able to be induced in 14 without neostigmine. In the remaining seven animals, four went into AF with the administration of neostigmine. One animal, not counted as a success, fibrillated for 20 seconds but did not receive neostigmine. It is possible that this animal, if given neostigmine, would have maintained AF for greater than 1 minute, thus making it an acceptable test subject for an antiarrhythmic intervention. Overall, AF was maintained for an average of 3.6 minutes. Our data show that the porcine atria represents a stable substrate for the induction and maintenance of AF and are, therefore, a good model for the acute screening of ablation technology and lesions sets. This study represents an easily reproducible, reliable protocol for inducible AF; furthermore, this is an acute protocol, requiring no previous intervention or chronic therapy.
With the introduction of new technologies and lesion sets to replace some or all of the surgical incisions of the Cox-Maze procedure, a model to test the effectiveness of these interventions needs to be used. Several substitutions can be used, including computer-based simulation, canine, caprine, ovine, and porcine models. Atrial fibrillation has been induced in both canine cardiac tissue and an ovine animal model. 15, 16 However, the porcine model has several advantages. These include the similarity of the size of the heart, the relative likeness of anatomy to humans, as well as the overall robustness of health in this animal. A porcine model in which AF is induced reliably is a valuable resource for testing the success of a new intervention for the treatment of AF. We have used this porcine model to test the efficacy of a new technology. 17 In one example, this was done by performing a modified Cox-Maze procedure, with minor modifications, with all lesions created with a bipolar radiofrequency ablation device. 17 We then confirmed success of the ablation by demonstrating an inability to induce AF using the method described. In addition, multiple other technologies have been evaluated in a similar fashion including radiofrequency, microwave, laser, and cryothermal. 18 This acute model permits the testing of many devices without the need for a chronic model.
Limitations
Although this experimental model demonstrated a high success rate, there were some important limitations. Multiple modes of inducing AF were used. Although these were treated similarly, they may actually simulate different mechanisms of AF and, therefore, have unique attributes impacting their preventability or treatability. Furthermore, the inability to achieve a 100% success rate may post logistic problems because it may necessitate a higher sample size to show a statistically significant difference if this model is used to evaluate a preventative therapy. Other modifications could be attempted to increase the success rate, such as left atrial stimulation. This may induce AF because of the shorter refractory period within the left atrium. Lastly, although a chronic animal model is more tedious and expensive, it likely offers a more representative model of the pathology and reversibility of this chronic disease in humans.
CONCLUSIONS
This series shows that the porcine heart will fibrillate reliably without chronic stimulation. In the majority of animals, rapid or burst pacing caused AF. The porcine heart is sensitive to stimulation, yet AF can be terminated by administration of bretylium or amiodarone. Because the porcine heart is sensitive to manipulation and rapid pacing, the inability to induce AF after creating a lesion set can be considered as a successful intervention. This model allows for the evaluation of new technologies, lesion patterns, and interventions for the treatment and prevention of AF.
